BamSEC and AlphaSense Join Forces
Learn More

MEI Pharma Inc.

NASDAQ: MEIP    
Share price (12/27/24): $2.44    
Market cap (12/27/24): $16.3 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 10-Q 5 pages Certificate of Amendment to Amended and Restated Certificate of Incorporation of MEI Pharma, Inc
12/34/56
EX-3.1
from 8-K 15 pages Sixth Amended and Restated Bylaws of MEI Pharma, Inc. Adopted as of December 18, 2023
12/34/56
EX-3.1
from 8-K 5 pages Certificate of Designation of Series a Junior Participating Preferred Stock of MEI Pharma, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Amended and Restated Certificate of Incorporation of MEI Pharma, Inc
12/34/56
EX-3.1
from 8-K 14 pages Fifth Amended and Restated By-Laws of MEI Pharma, Inc. Adopted as of February 22, 2023
12/34/56
EX-3.1
from 8-K 18 pages Fourth Amended and Restated By-Laws of MEI Pharma, Inc. Adopted as of December 16, 2021
12/34/56
EX-3.1
from 8-K 18 pages Third Amended and Restated By-Laws of MEI Pharma, Inc. Adopted as of March 18, 2020
12/34/56
EX-3.1
from 10-Q 7 pages State of Delaware Secretary of State Division of Corporations Delivered 04:15 Pm 11/29/2018 Filed 04:15 Pm 11/29/2018 Sr 20187877521 - File Number 3323531 Amended and Restated Certificate of Incorporation of MEI Pharma, Inc
12/34/56
EX-3.1
from 10-Q 13 pages Second Amended and Restated By-Laws of MEI Pharma, Inc. Adopted as of March 17, 2016
12/34/56
EX-3.1
from 8-K 10 pages Second Amended and Restated By-Laws of MEI Pharma, Inc. Adopted as of March 17, 2016
12/34/56
EX-3.1
from 8-K 13 pages Amended and Restated By-Laws of MEI Pharma, Inc. Adopted as of March 21, 2014
12/34/56
EX-3.2
from 8-K 9 pages Amended and Restated By-Laws of MEI Pharma, Inc. Adopted as of December 18, 2012
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Restated Certificate of Incorporation of MEI Pharma, Inc. Pursuant to Sections 228 and 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from 8-K 8 pages Amended and Restated By-Laws of MEI Pharma, Inc. Adopted as of July 2, 2012
12/34/56
EX-3.1
from 8-K 5 pages Unanimous Written Consent in Lieu of a Meeting of the Board of Directors of Marshall Edwards, Inc. June 20, 2012
12/34/56
EX-3.1
from 8-K 9 pages Certificate of Designation of Series a Convertible Preferred Stock of Marshall Edwards, Inc. May 9, 2011 Pursuant to the General Corporation Law of the State of Delaware
12/34/56
EX-3.1.1
from 8-K 1 page Certificate of Amendment to the Restated Certificate of Incorporation of Marshall Edwards, Inc. Pursuant to Sections 228 and 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 14 pages Amended and Restated By-Laws of Marshall Edwards, Inc. Adopted as of July 27, 2007
12/34/56
EX-3.1
from 8-K 13 pages Amended and Restated By-Laws of Marshall Edwards, Inc. Adopted as of December 5, 2006
12/34/56
EX-3.2
from S-1 ~10 pages Articles of Incorporation or Bylaws
12/34/56